{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "8593452", "DateCompleted": {"Year": "1996", "Month": "04", "Day": "08"}, "DateRevised": {"Year": "2019", "Month": "07", "Day": "19"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0918-6158", "JournalIssue": {"Volume": "18", "Issue": "10", "PubDate": {"Year": "1995", "Month": "Oct"}}, "Title": "Biological & pharmaceutical bulletin", "ISOAbbreviation": "Biol Pharm Bull"}, "ArticleTitle": "Panax ginseng extract improves the scopolamine-induced disruption of 8-arm radial maze performance in rats.", "Pagination": {"StartPage": "1439", "EndPage": "1442", "MedlinePgn": "1439-42"}, "Abstract": {"AbstractText": ["The effects of Panax ginseng ethanol extract and its water (WSF)- and lipid-soluble (LSF) fractions on the scopolamine-induced disruption of radial maze performance in rats were examined. Ginseng root was refluxed with ethanol, and WSF and LSF were prepared from this ethanol extract. Scopolamine (0.075-0.3 mg/kg, i.p.) dose-dependently impaired the maze performance. However, the oral administration of Panax ginseng ethanol extract and WSF (2-8 g dried root/kg) 90 min before testing improved the maze performance disrupted by scopolamine (0.3 mg/kg) in a dose-dependent manner, but LSF failed to attenuate the disruption. These data suggest that ginseng extract possesses a beneficial effect regarding spatial cognitive impairment and that the water-soluble fraction of ginseng extract mainly contributes to the effect of the ethanol extract."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmacology, Research Institute for Wakan-Yaku (Oriental Medicines, Toyama, Japan."}], "LastName": "Nitta", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Matsumoto", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Shimizu", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ni", "ForeName": "X H", "Initials": "XH"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Watanabe", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Biol Pharm Bull", "NlmUniqueID": "9311984", "ISSNLinking": "0918-6158"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Parasympatholytics"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "DL48G20X8X", "NameOfSubstance": "Scopolamine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Maze Learning"}, {"QualifierName": ["chemistry"], "DescriptorName": "Panax"}, {"QualifierName": ["antagonists & inhibitors", "pharmacology"], "DescriptorName": "Parasympatholytics"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["antagonists & inhibitors", "pharmacology"], "DescriptorName": "Scopolamine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1995", "Month": "10", "Day": "1"}, {"Year": "1995", "Month": "10", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1995", "Month": "10", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["8593452", "10.1248/bpb.18.1439"]}}]}